In short, B-T cells were exclusively identified in UBC, which highly expressed IGHG2, IGHG1, JCHAIN and CD79A. The gene expression signature of B-T cells was associated with poor prognosis of patients with UBC and other tumor types. This evidence concerns the gene CD79A and neoplasm.